|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 39 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-10-31 |
4 |
S |
$11.70 |
$285,183 |
I/I |
(24,384) |
1,305,666 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-27 |
4 |
S |
$21.58 |
$531,786 |
I/I |
(24,486) |
257,293 |
|
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-10 |
4 |
B |
$26.52 |
$653,635 |
I/I |
24,582 |
1,372,864 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-12-03 |
4 |
S |
$12.16 |
$299,000 |
I/I |
(24,587) |
1,056,845 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-24 |
4 |
B |
$16.31 |
$402,984 |
I/I |
24,655 |
1,068,923 |
2.25 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2016-02-04 |
4 |
B |
$6.65 |
$164,915 |
I/I |
24,800 |
12,849,240 |
1.5 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2009-02-06 |
4 |
S |
$8.17 |
$203,358 |
I/I |
(24,879) |
190,917 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-09 |
4 |
B |
$4.77 |
$118,733 |
I/I |
24,899 |
879,109 |
1.5 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2016-01-28 |
4 |
B |
$6.88 |
$172,015 |
I/I |
25,000 |
12,641,525 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-12-06 |
4 |
S |
$12.35 |
$311,323 |
I/I |
(25,202) |
1,004,905 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-06-30 |
4 |
S |
$14.99 |
$377,846 |
I/I |
(25,202) |
576,309 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-04-29 |
4 |
B |
$12.98 |
$328,600 |
I/I |
25,243 |
229,394 |
1.5 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2007-06-19 |
4 |
S |
$5.64 |
$143,750 |
I/I |
(25,265) |
203,150 |
0 |
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2012-03-12 |
4 |
B |
$1.87 |
$61,629 |
I/I |
25,304 |
51,126 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-02-07 |
4 |
B |
$9.00 |
$231,681 |
I/I |
25,744 |
7,512,744 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-23 |
4 |
B |
$4.07 |
$106,342 |
I/I |
26,145 |
3,214,580 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-23 |
4 |
B |
$16.40 |
$432,557 |
I/I |
26,373 |
1,044,268 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-15 |
4 |
S |
$11.77 |
$311,031 |
I/I |
(26,415) |
1,100,592 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-12 |
4 |
B |
$5.58 |
$148,020 |
I/I |
26,535 |
92,120 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-12-01 |
4 |
B |
$27.33 |
$725,256 |
I/I |
26,537 |
1,286,841 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-05-11 |
4 |
B |
$30.22 |
$805,567 |
I/I |
26,660 |
235,167 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-09-26 |
4 |
B |
$18.13 |
$485,450 |
I/I |
26,781 |
1,843,530 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2009-08-12 |
4 |
B |
$19.70 |
$528,034 |
I/I |
26,808 |
3,760,190 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-31 |
4 |
B |
$14.37 |
$389,584 |
I/I |
26,919 |
4,891,182 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-20 |
4 |
B |
$14.51 |
$395,875 |
I/I |
27,272 |
4,672,660 |
2.25 |
- |
|
1397 Records found
|
|
Page 39 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|